4 studies found for:    16122679 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b
2 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL with Ribavirin;   Drug: Chlorcyclizine HCL
3 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
4 Recruiting Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection
Conditions: Hepatitis C;   Lichen Planus;   Vasculitis;   Autoimmune Diseases
Interventions: Drug: Ribavirin;   Drug: Betamethasone

Indicates status has not been verified in more than two years